$15.13
0.060.4%
Last update: Nov 5, 8:16 AM
Ascentage Pharma Group International
AAPGNASDAQ
The average analyst price target for Ascentage Pharma Group is $44.56, 182.0% above the current price. Of 9 analysts, 9 rate it Buy. Targets range from $33 to $51. The latest change came on Oct 16, 2026, when William Blair initiated coverage of Ascentage Pharma Group with an Outperform rating.
Price Target Range — 5 Quarters
Analyst Consensus — 9 Analysts
Rating Trend — Last 9 Months
